Plasma cholesterol, hepatic lipid, and gallstones were lower in CREBH Tg mice.
Expression of intestinal Npc1l1 was reduced in CREBH Tg mice.
CREBH directly down-regulates mouse Npc1l1 promoter activity.
Intestinal CREBH regulates dietary cholesterol flow from the small intestine.